Table 2.

Description of the three fatalities in children and young people with COVID-19

Patient	Age	Sex	Rheumatology diagnosis	Comorbidities	Glucocorticoids	Rheumatology treatment	Disease activity	Time from COVID-19 onset to death
1	<15 years	Female	Systemic lupus erythematosus	None	None	Antimalarials Intravenous Immunoglobulin	High	8 days
2	<10 years	Female	Systemic lupus erythematosus	None	Yes (dose unknown)	None	High	9 days
3	<5 years	Female	Auto-inflammatory syndrome	None	Yes (low dose)	Methotrexate	Unknown	7 days